Revance Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.7M | 326k | 5.19 |
| 2024-06-30 | $959k | 373k | 2.57 |
| 2024-03-31 | $1.5M | 305k | 4.92 |
| 2023-12-31 | $2.9M | 335k | 8.79 |
| 2023-09-30 | $4.4M | 386k | 11.47 |
| 2023-06-30 | $9.4M | 373k | 25.31 |
| 2023-03-31 | $10M | 309k | 32.21 |
| 2022-12-31 | $5.8M | 313k | 18.46 |
| 2022-09-30 | $8.3M | 309k | 26.82 |
| 2022-06-30 | $3.6M | 259k | 13.82 |
| 2022-03-31 | $5.4M | 275k | 19.51 |
| 2021-12-31 | $4.5M | 276k | 16.44 |
| 2021-09-30 | $7.5M | 271k | 27.86 |
| 2021-06-30 | $7.4M | 251k | 29.65 |
| 2021-03-31 | $11M | 377k | 27.95 |
| 2020-12-31 | $10M | 358k | 28.34 |
| 2020-09-30 | $7.9M | 313k | 25.14 |
| 2020-06-30 | $6.8M | 279k | 24.39 |
| 2020-03-31 | $3.9M | 262k | 14.79 |
| 2019-12-31 | $5.3M | 328k | 16.23 |
| 2019-09-30 | $14M | 1.1M | 13.00 |
| 2019-06-30 | $29M | 2.3M | 12.97 |
| 2019-03-31 | $36M | 2.3M | 15.76 |
| 2018-12-31 | $51M | 2.5M | 20.13 |
| 2018-09-30 | $61M | 2.5M | 24.85 |
| 2018-06-30 | $53M | 1.9M | 27.45 |
| 2018-03-31 | $62M | 2.0M | 30.80 |
| 2017-12-31 | $77M | 2.1M | 35.74 |
| 2017-06-30 | $55M | 2.1M | 26.40 |
| 2017-03-31 | $38M | 1.8M | 20.81 |
| 2016-12-31 | $40M | 1.9M | 20.69 |
| 2016-09-30 | $31M | 1.9M | 16.22 |
| 2016-06-30 | $29M | 2.1M | 13.61 |